# Siddarth Selvaraj

> Siddarth (Sid) Selvaraj is the co-founder and former CEO of Arima Genomics, now listed by the company as founder and chief operating officer. A UC San Diego bioinformatics PhD, he helped translate research on three-dimensional genome organization into commercial laboratory kits and built research partnerships during his decade as CEO. His public accounts emphasize customer discovery, product refinement and the practical work of commercialization.

- **Role:** Founder and Chief Operating Officer at Arima Genomics
- **Organizations:** Arima Genomics, University of California San Diego, Carevoyant Technologies
- **Education:** PhD, Bioinformatics and Systems Biology, University of California San Diego
- **Known for:** Co-founded Arima Genomics and led it as founding CEO for approximately ten years., Co-authored the 2013 Nature Biotechnology paper on whole-genome haplotype reconstruction., Helped establish a commercial kit business with product sales beginning in 2018.

## Career timeline

- **Before doctoral research** — Worked as a software engineer at Carevoyant Technologies; this employment is documented in his public speaker biography.
- **2010–2014** — Doctoral studies at UC San Diego, as listed on his LinkedIn profile; thesis on 3D genome organization and gene regulation, advised by Bing Ren and Vineet Bafna.
- **2013** — Co-authored Nature Biotechnology research on whole-genome haplotype reconstruction with Jesse Dixon, Vikas Bansal and Bing Ren.
- **2015** — Founded Arima Genomics to commercialize doctoral research; served as CEO through June 2025.
- **2017** — Arima participated in I-Corps at NIH; customer discovery helped establish a kit-based distribution model.
- **2018** — Arima began commercial sales of its genomic kits.
- **2020** — During his CEO tenure, Wellcome Sanger Institute selected Arima as a Hi-C technology partner.
- **2021** — Arima announced a European Reference Genome Atlas partnership and Japanese distribution partnership.
- **2024** — Shared commercialization advice on the SBIR Innovation Lab podcast.
- **2025** — Arima announced a $22 million Series C; Tom Willis became CEO and Selvaraj continued as president and COO.

## Achievements

- Co-founded Arima Genomics and led it as founding CEO for approximately ten years.
- Co-authored the 2013 Nature Biotechnology paper on whole-genome haplotype reconstruction.
- Helped establish a commercial kit business with product sales beginning in 2018.
- Led Arima during its 2020 selection as a Hi-C technology partner by the Wellcome Sanger Institute.

## Latest updates

- **2025-06** — Continued as president and COO after Tom Willis was appointed CEO; Arima simultaneously announced a $22 million Series C.
- **2026-10** — Leadership page checked in October 2026 lists him as founder and COO and as a board director; this is a verification date, not an announced appointment date.

## Links

- LinkedIn: https://www.linkedin.com/in/sidselvaraj

---

Profile page: https://yespress.io/siddarth-selvaraj
Published by YesPress — https://yespress.io
Last updated: 2026-10-15